Alok Sonig's most recent trade in Baxter International Inc. was a trade of 99,905 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Baxter International | Alok Sonig | EVP,Group President,Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 99,905 | 99,905 | - | - | Stock Option (Right to Buy) | |
| Baxter International | Alok Sonig | EVP,Group President,Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 29,966 | 130,298 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | Alok Sonig | EVP,Group President,Pharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.44 per share. | 06 Mar 2025 | 10,839 | 100,332 (0%) | 0% | 35.4 | 384,134 | Common Stock, $1 par value |
| Baxter International | Alok Sonig | EVP,Group President,Pharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.86 per share. | 03 Mar 2025 | 1,936 | 111,171 (0%) | 0% | 34.9 | 67,489 | Common Stock, $1 par value |
| Baxter International | Alok Sonig | EVP,Group President, Pharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.85 per share. | 03 Sep 2024 | 3,054 | 111,603 (0%) | 0% | 37.9 | 115,594 | Common Stock, $1 par value |
| Baxter International | Alok Sonig | EVP,Group President, Pharma | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 83,353 | 113,454 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | Alok Sonig | EVP, Group President, Pharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.01 per share. | 01 Mar 2024 | 1,832 | 30,101 (0%) | 0% | 41.0 | 75,130 | Common Stock, $1 par value |
| Baxter International | Alok Sonig | EVP, Group President, Pharm | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.60 per share. | 01 Sep 2023 | 2,059 | 31,512 (0%) | 0% | 40.6 | 83,595 | Common Stock, $1 par value |
| Baxter International | Alok Sonig | EVP, Group President, Pharm | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 63,965 | 63,965 | - | - | Stock Option (Right to Buy) | |
| Baxter International | Alok Sonig | EVP, Group President, Pharm | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 15,428 | 33,226 (0%) | 0% | 0 | Common Stock, $1 par value |